Orlifit™

Therapeutic Segment:

Anti-Obesity

Generic Name:

Orlistat

Indication

Capsule
  • 120MG

Indicated for:
• Dietary modification (reduced calorie diet) in the management of obesity, i.e. in patients with a BMI of 30Kg/m2 or greater
• Overweight patients with BMI of 27Kg/m2 or more with associated risk factors e.g., (hypertension, diabetes, dyslipidemia).